Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$11.39 - $13.72 $142,033 - $171,088
12,470 New
12,470 $158,000
Q3 2022

Nov 14, 2022

SELL
$11.61 - $15.22 $704,018 - $922,925
-60,639 Reduced 93.37%
4,307 $50,000
Q2 2022

Aug 09, 2022

BUY
$14.32 - $19.88 $930,026 - $1.29 Million
64,946 New
64,946 $958,000
Q1 2022

May 13, 2022

SELL
$15.39 - $20.25 $733,118 - $964,629
-47,636 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$15.91 - $18.72 $757,888 - $891,745
47,636 New
47,636 $821,000
Q3 2021

Nov 15, 2021

SELL
$13.06 - $17.24 $51,247 - $67,649
-3,924 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$11.45 - $13.96 $1.87 Million - $2.28 Million
-163,064 Reduced 97.65%
3,924 $52,000
Q1 2021

May 14, 2021

BUY
$11.06 - $12.87 $1.7 Million - $1.98 Million
153,890 Added 1174.91%
166,988 $2 Million
Q4 2020

Feb 11, 2021

SELL
$9.33 - $12.48 $973,230 - $1.3 Million
-104,312 Reduced 88.84%
13,098 $162,000
Q3 2020

Nov 13, 2020

SELL
$10.33 - $14.49 $1.58 Million - $2.22 Million
-153,316 Reduced 56.63%
117,410 $1.23 Million
Q2 2020

Aug 13, 2020

BUY
$11.49 - $15.26 $3.11 Million - $4.13 Million
270,726 New
270,726 $3.78 Million
Q1 2019

May 13, 2019

SELL
$13.69 - $20.06 $5,886 - $8,625
-430 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$13.96 - $18.26 $2.63 Million - $3.44 Million
-188,219 Reduced 99.77%
430 $7,000
Q2 2016

Jul 29, 2019

SELL
N/A
-472,185 Reduced 71.45%
188,649 $1.99 Million
Q1 2016

Jul 25, 2019

BUY
N/A
660,834
660,834 $8.32 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.22B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.